Old Web
English
Sign In
Acemap
>
authorDetail
>
Lars Erwig
Lars Erwig
GlaxoSmithKline
Medicine
Pharmacodynamics
Adverse effect
Pharmacokinetics
Placebo
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Randomized Study of the Safety and Pharmacokinetics of GSK3358699, a Mononuclear Myeloid-Targeted Bromodomain and Extra-Terminal Domain Inhibitor
2021
British Journal of Clinical Pharmacology
Jack A. Brown
Joanne Bal
Monica Simeoni
Peter Williams
Palwinder K. Mander
Peter Ernest Soden
Shruti Daga
William A. Fahy
Gabriel K. Wong
Jackie C. Bloomer
Lars Erwig
Yi Cui
Disala Fernando
Helen Carnaghan
Edward Banham-Hall
Sarah J Hopkins
Bill Davis
João Joaquim Oliveira
Rab K. Prinjha
Show All
Source
Cite
Save
Citations (0)
Multimorbidity in Anti‐Neutrophil Cytoplasmic Antibody‐associated vasculitis: results from a longitudinal, multi‐centre data‐linkage study
2020
Arthritis & Rheumatism
Shifa Sarica
Peter J. Gallacher
Neeraj Dhaun
J Sznajd
John Harvie
John McLaren
Lucy McGeoch
Vinod Kumar
Nicole Amft
Lars Erwig
Angharad Marks
Laura Bruno
York Zöllner
Corri Black
Neil Basu
Show All
Source
Cite
Save
Citations (1)
Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double‐blind Phase Ib study
2020
Experimental Dermatology
Alex Walker
Lars Erwig
Katie Foster
Katherine Nevin
Joerg Wenzel
Margitta Worm
Nicola Williams
Nirav Ratia
Bâo Hoang
Tanja Schneider‐Merck
Sophie Gisbert
Heike Carnarius
Marion C. Dickson
Show All
Source
Cite
Save
Citations (1)
1
map